As of 2025-09-18, the Relative Valuation of Solid Biosciences Inc (SLDB) is (17.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.47 USD, the upside of Solid Biosciences Inc based on Relative Valuation is -415.6%.
The range of the Relative Valuation is (13.53) - (22.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.5x - 11.5x | 8.0x |
| Forward P/E multiples | 6.8x - 12.1x | 9.4x |
| Fair Price | (13.53) - (22.83) | (17.26) |
| Upside | -347.4% - -517.5% | -415.6% |
| Date | P/E |
| 2025-09-12 | -2.72 |
| 2025-09-11 | -2.68 |
| 2025-09-10 | -2.65 |
| 2025-09-09 | -2.53 |
| 2025-09-08 | -2.59 |
| 2025-09-05 | -2.78 |
| 2025-09-04 | -2.81 |
| 2025-09-03 | -2.91 |
| 2025-09-02 | -2.74 |
| 2025-08-29 | -2.77 |
| 2025-08-28 | -2.84 |
| 2025-08-27 | -2.84 |
| 2025-08-26 | -2.89 |
| 2025-08-25 | -2.83 |
| 2025-08-22 | -3.00 |
| 2025-08-21 | -2.86 |
| 2025-08-20 | -2.86 |
| 2025-08-19 | -2.93 |
| 2025-08-18 | -3.05 |
| 2025-08-15 | -3.09 |
| 2025-08-14 | -3.12 |
| 2025-08-13 | -3.38 |
| 2025-08-12 | -3.05 |
| 2025-08-11 | -3.07 |
| 2025-08-08 | -3.18 |
| 2025-08-07 | -3.13 |
| 2025-08-06 | -3.29 |
| 2025-08-05 | -3.39 |
| 2025-08-04 | -3.45 |
| 2025-08-01 | -3.45 |
| 2025-07-31 | -3.46 |
| 2025-07-30 | -3.57 |
| 2025-07-29 | -3.57 |
| 2025-07-28 | -3.55 |
| 2025-07-25 | -3.54 |
| 2025-07-24 | -3.38 |
| 2025-07-23 | -3.42 |
| 2025-07-22 | -3.15 |
| 2025-07-21 | -3.22 |
| 2025-07-18 | -3.23 |
| 2025-07-17 | -2.93 |
| 2025-07-16 | -2.82 |
| 2025-07-15 | -2.72 |
| 2025-07-14 | -2.76 |
| 2025-07-11 | -2.66 |
| 2025-07-10 | -2.74 |
| 2025-07-09 | -2.79 |
| 2025-07-08 | -2.65 |
| 2025-07-07 | -2.48 |
| 2025-07-03 | -2.54 |